Search Results for: darvocet

Featured Stories

Medtronic Infuse Lawsuit Alleges Off-Label Use Cause Painful Complications

A man in Louisiana has filed suit against Medtronic Inc. over injuries allegedly cause by off-label use of its Infuse Bone Graft product. The plaintiff, who received Infuse during transforaminal spinal lumbar fusion surgery, claims that the bone growth protein caused unwanted bone growth along his spine, worsening the back ...

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

System for Tracking Prescription Drug Side Effects Flawed

Study Finds System for Tracking Prescription Drug Side Effects Flawed

System for keeping track of dangerous side effects of prescription drugs is flawed because drug makers are submitting incomplete information about problems to the FDA.

Read More

Whistleblower Wins Retaliation - Canaveral National Seashore

Whistleblower Wins Retaliation Lawsuit

A whistleblower who reported misconduct at Canaveral National Seashore has won a retaliation ruling against the U.S. Department of Interior, Florida Today reports.

Read More

Study Finds Metal-on-Metal Hip Implants Associated with High Incidence of Pseudotumors

Yet another study is adding to concerns about the potential dangers associated with metal-on-metal hip implants. The study, published in the Journal of Bone and Joint Surgery, found that large diameter metal-on-metal total hip replacement may be associated with a substantially higher incidence of pseudotumor formation.

Read More

Stryker Issues Voluntary Recall for Rejuvenate Modular and ABG II Hip Implant Components

Stryker Orthopedics is recalling two metal-on-metal hip implant components, its Rejuvenate Modular and ABG II modular-neck hip stems. According to a notice posted on Stryker’s website, risks associated with the Rejuvenate Modular and ABG II modular-neck hip stems include the potential for fretting and/or corrosion at or about ...

Read More

Geodon the antipsychotic drug can Cause Deadly Skin Reaction

Geodon can Cause Deadly Skin Reaction, FDA Warns

The FDA has required a new warning label for the antipsychotic drug Geodon (ziprasidone) to include the risk of a potentially fatal skin reaction.

Read More

Bayer Yaz, Yasmin Blood Clot Lawsuit Settlements Stand at $147 Million

Bayer AG reported yesterday that it continues to settle Yaz and Yasmin birth control pill lawsuits. According to a report from Bloomberg News, the company said in its latest Stockholder Newsletter that it has settled 651 Yaz and Yasmin blood clot lawsuits for a total of $147 million. The average ...

Read More

New Study Links Metal-on-Metal Hip Replacement Corrosion with Adverse Local Tissue Reactions

Yet another study is pointing to potential dangers posed by metal-on-metal hip implants. This time, an article published in the Journal of Arthroplasty is reporting corrosion in the head taper junction was more likely to occur in patients with 36-mm diameter metal-on-metal hip replacement, compared to those with the same ...

Read More

Dozens Receive Nonsterile Simulated Saline Solution


The FDA said last week that more than 40 patients had received intravenous simulated saline that was not sterile and was not intended for human use.

Read More

Thousands of Darvon, Darvocet Lawsuits Expected

Personal injury attorneys are preparing Darvocet and < "">Darvon litigation against the makers of propoxyphene-based painkillers. It seems that the alleged cardiac response to the drugs could be fatal with erratic origins that provide no symptoms, noted the Daily Mail. Attorneys … Continue reading

Posted in Pharmaceuticals, Product Recalls, Recalled Drugs |

Motion Filed to Consolidate Darvon, Darvocet Lawsuits in Multidistrict Litigation

Attorneys representing a 31-year-old Queens, New York Woman in a < "">Darvocet lawsuit have petitioned the Judicial Panel on Multidistrict Litigation to consolidate all federal lawsuits involving Darvon, Darvocet and other propoxyphene medications in a multidistrict litigation in US District … Continue reading

Posted in Legal News, Pharmaceuticals |

Darvon, Darvocet Recall Delay May Have Killed Thousands

How many Darvon and Darvocet deaths may have occurred while the US Food & Drug Administration (FDA) waited to pull these and other dangerous propoxyphene-based drugs from the market? It’s probably impossible to know for sure, but according to the … Continue reading

Posted in Pharmaceuticals |

Darvon, Darvocet, Other Narcotic Painkillers May Put Elderly at Risk for Heart Attacks, Other Side Effects

Narcotic painkillers, a class of drugs that includes Oxycontin, as well as the now-recalled medications Darvon and Darvocet, may increase the risk of heart attacks and bone fractures in elderly arthritis patients, a new study has found. According to a … Continue reading

Posted in Pharmaceuticals |

Darvocet Lawsuit Filed on Behalf of New York Woman

A < "">Darvocet lawsuit has been filed on behalf a 31-year-old New York woman who says the recalled painkiller caused her to suffer a near-fatal cardiac arrhythmia. The plaintiff is being represented by the national < "">personal injury law firm … Continue reading

Posted in Legal News, Pharmaceuticals |

Darvocet Class Action Lawsuit Says Painkiller Caused Heart Attack

A propoxyphene-containing painkiller has been named in a Darvocet class action lawsuit filed by a woman who claims it caused her to suffer a heart attack. Darvocet, as well as Darvon, were pulled from the market by Xanodyne Pharmaceuticals Inc. … Continue reading

Posted in Pharmaceuticals |

Darvon, Darvocet Recall Came 30 Years Too Late

The Darvon and Darvocet recall announced last month due to the drugs’ association with serious and sometimes fatal heart rhythm problems was about 30 years too late. For at least that long, patient advocates had raised questions about the safety … Continue reading

Posted in Pharmaceuticals |

Darvon, Darvocet Withdrawal Prompts Other Propoxyphene Recalls

Following the earlier Darvon and Darvocet recall by Xanodyne Pharmaceuticals Inc., makers of generic propoxyphene medications have begun recalling their products. Recently, Cornerstone Therapeutics Inc. said it would remove three such propoxyphene products from the market, including Balacet 325. Propoxyphene … Continue reading

Posted in Pharmaceuticals |

Darvon, Darvocet Patients Should Discuss Alternatives with Their Doctors

The recent Darvocet and Darvon recall from the market because of their association with dangerous, and even fatal heart rhythm problems has caused consternation among people who relied on Darvon and Darvocet to manage chronic pain. But according to a recent article … Continue reading

Posted in Pharmaceuticals |

Darvon, Darvocet Withdrawal Late in Coming

The decision to finally pull Darvon and Darvocet from the market has spawned criticism of the US Food & Drug Administration (FDA) by those who say it waited too long to act on the dangerous painkillers. Darvon and Darvocet have … Continue reading

Posted in Pharmaceuticals |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.